2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015 or KB) is a new drug, structurally related to amiodarone and to thyroid hormones. Its effects on cardiac voltagedependent Na ϩ current (I Na ) were studied in pig single ventricular myocytes at 22°C using the whole-cell (with [Na ϩ ] i ϭ [Na ϩ ] o ϭ 10 mM) and cell-attached patch-clamp techniques. KB markedly slowed I Na inactivation, due to the development of a slow-inactivating component ( slow Ϸ 50 ms) at the expense of the normal, fast-inactivating component ( fast Ϸ 2-3 ms). The effect was concentration-dependent, with a half-maximally effective concentration (K 0.5 ) of 2.1 M. KB also slowed the recovery from inactivation and shifted the voltage-dependent inactivation (⌬V 0.5 ϭ Ϫ15 mV; K 0.5 Ն 6.9 M) and activation to more negative potentials. Intracellular cell dialysis with 10 M KB had marginal or no effect on inactivation and did not prevent the effect of extracellularly applied drug. In cell-attached patches, extracellular KB prolonged Na ϩ channel opening. Amiodarone (10 M) and 10 M 3,5,-diiodo-L-thyropropionic acid had no effect on inactivation and did not prevent KB effects. 3,3Ј,5-Triodo-L-thyronine (T 3 ) also had no effect on inactivation, but at 10 M it increased I Na amplitude and partially prevented the slowing of inactivation by KB. These data suggest the existence of a binding site for KB and T 3 on Na ϩ channels.Voltage-dependent Na ϩ channels play an important role in the initiation and conduction of electrical signals in excitable cells. A dysfunction of Na ϩ channels, as may occur after genetic mutation or as a consequence of drug action, is the basis for a variety of cardiac arrhythmias (e.g., those related to the long QT and the Brugada syndromes), skeletal muscle diseases, and epileptic seizures (for reviews, see Fozzard and